Human RAF1 (Raf Proto-Oncogene Serine/Threonine-Protein Kinase) - Recombinant Protein
Beta LifeScience
            SKU/CAT #: BLT-08935P
          
       
 
    SDS-PAGE analysis of Human RAF1 (Raf Proto-Oncogene Serine/Threonine-Protein Kinase) - Recombinant Protein, CAT# BLT-08935P showing >90% purity under 15% SDS-PAGE (Reduced)
  
Human RAF1 (Raf Proto-Oncogene Serine/Threonine-Protein Kinase) - Recombinant Protein
Beta LifeScience
            SKU/CAT #: BLT-08935P
          
            
                      
                            Regular price
                        
                        
                          $59500
  $595.00
                        
                        Sale price$54500
  $545.00Save $50
/
                      
                    Quantity Pricing
| Pack Size | Price (USD) | 
|---|---|
| 500 µg | $1,375 | 
| 1 mg | $2,245 | 
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human RAF proto-oncogene serine/threonine-protein kinase (RAF1) Protein | 
| Product Overview | This recombinant human RAF proto-oncogene serine/threonine-protein kinase (RAF1) protein includes amino acids 306-648(Y430A&S499A&Y534A) of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitolprior to lyophilization. | 
| Target Uniprot Id | P04049 | 
| Recommended Name | RAF proto-oncogene serine/threonine-protein kinase | 
| Gene Name | RAF1 | 
| Species | Human | 
| Predicted Molecular Mass | 42 kDa | 
| Expression System | E.coli | 
| Expression Range | 306-648(Y430A&S499A&Y534A) | 
| Tag | N-6His | 
| Purity | >90% | 
| Formulation | Lyophilized | 
| Buffer | PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitol | 
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. | 
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. | 
| Applications | Positive Control; Immunogen; SDS-PAGE; WB | 
| Research Area | Cancer | 
| Target Function | Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. | 
| Subcellular Location | Cytoplasm. Cell membrane. Mitochondrion. Nucleus. Note=Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus. | 
| Protein Family | Protein kinase superfamily, TKL Ser/Thr protein kinase family, RAF subfamily | 
| Associated Diseases | Noonan syndrome 5 (NS5); LEOPARD syndrome 2 (LPRD2); Cardiomyopathy, dilated 1NN (CMD1NN) | 
| Tissue Specificity | In skeletal muscle, isoform 1 is more abundant than isoform 2. | 
 
         
       
           
        
 
           
          ![SDS-PAGE analysis of Human NDUFV1 (Nadh Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial) - Recombinant Protein, CAT# BLT-08321P, showing >90% purity under 15% SDS-PAGE (Reduced)](http://www.betalifesci.com/cdn/shop/files/1ihmbkjr21vdmc6j_{width}x.jpg?v=1753363793) 
           
           
          